CAT-8015 (moxetumomab pasudotox)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAT-8015 (moxetumomab pasudotox), covering 2017-04-12 to 2017-04-12. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia [Phase 1]